全文获取类型
收费全文 | 3826篇 |
免费 | 194篇 |
国内免费 | 32篇 |
专业分类
耳鼻咽喉 | 15篇 |
儿科学 | 105篇 |
妇产科学 | 30篇 |
基础医学 | 443篇 |
口腔科学 | 77篇 |
临床医学 | 313篇 |
内科学 | 1052篇 |
皮肤病学 | 56篇 |
神经病学 | 257篇 |
特种医学 | 112篇 |
外科学 | 808篇 |
综合类 | 22篇 |
预防医学 | 76篇 |
眼科学 | 14篇 |
药学 | 271篇 |
中国医学 | 30篇 |
肿瘤学 | 371篇 |
出版年
2023年 | 25篇 |
2022年 | 30篇 |
2021年 | 94篇 |
2020年 | 67篇 |
2019年 | 72篇 |
2018年 | 88篇 |
2017年 | 67篇 |
2016年 | 62篇 |
2015年 | 72篇 |
2014年 | 107篇 |
2013年 | 122篇 |
2012年 | 223篇 |
2011年 | 227篇 |
2010年 | 108篇 |
2009年 | 96篇 |
2008年 | 208篇 |
2007年 | 184篇 |
2006年 | 191篇 |
2005年 | 230篇 |
2004年 | 208篇 |
2003年 | 179篇 |
2002年 | 185篇 |
2001年 | 72篇 |
2000年 | 88篇 |
1999年 | 85篇 |
1998年 | 67篇 |
1997年 | 51篇 |
1996年 | 41篇 |
1995年 | 43篇 |
1994年 | 35篇 |
1993年 | 35篇 |
1992年 | 62篇 |
1991年 | 59篇 |
1990年 | 61篇 |
1989年 | 54篇 |
1988年 | 45篇 |
1987年 | 48篇 |
1986年 | 37篇 |
1985年 | 42篇 |
1984年 | 32篇 |
1983年 | 32篇 |
1982年 | 17篇 |
1981年 | 12篇 |
1979年 | 19篇 |
1978年 | 20篇 |
1977年 | 19篇 |
1974年 | 14篇 |
1973年 | 13篇 |
1971年 | 16篇 |
1970年 | 19篇 |
排序方式: 共有4052条查询结果,搜索用时 15 毫秒
131.
132.
We describe a patient who underwent radiofrequency (RF) catheter ablation of cavo-tricuspid isthmus-dependent atrial flutter (AFL). Extensive ablation at the isthmus failed to terminate the AFL. A coronary sinus (CS) diverticulum arising from the proximal portion of the middle cardiac vein was found near the isthmus. An RF energy application at the bottom of the CS diverticulum resulted in completion of a bidirectional block line at the isthmus, as well as AFL termination. 相似文献
133.
134.
135.
Higashi N Taniguchi M Mita H Yamaguchi H Ono E Akiyama K 《Allergology international》2012,61(3):393-403
The clinical syndrome of aspirin-intolerant asthma (AIA) is characterized by aspirin/nonsteroidal anti-inflammatory drug intolerance, bronchial asthma, and chronic rhinosinusitis with nasal polyposis. AIA reactions are evidently triggered by pharmacological effect of cyclooxygenase-1 inhibitors. Urine sampling is a non-invasive research tool for time-course measurements in clinical investigations. The urinary stable metabolite concentration of arachidonic acid products provides a time-integrated estimate of the production of the parent compounds in vivo. AIA patients exhibits significantly higher urinary concentrations of leukotriene E(4) (LTE(4)) and 1,15-dioxo-9α-hydroxy-2,3,4,5-tetranorprostan-1,20-dioic acid (tetranor-PGDM), a newly identified metabolite of PGD(2), at baseline. This finding suggests the possibility that increased mast cell activation is involved in the pathophysiology of AIA even in a clinically stable condition. In addition, lower urinary concentrations of primary prostaglandin E(2) and 15-epimer of lipoxin A(4) at baseline in the AIA patients suggest that the impaired anti-inflammatory elements may also contribute to the severe clinical outcome of AIA. During the AIA reaction, the urinary concentrations of LTE(4) and PGD(2) metabolites, including tetranor-PGDM significantly and correlatively increase. It is considered that mast cell activation probably is a pathophysiologic hallmark of AIA. However, despite the fact that cyclooxygenease-1 is the dominant in vivo PGD(2) biosynthetic pathway, the precise mechanism underlying the PGD(2) overproduction resulting from the pharmacological effect of cyclooxygenease-1 inhibitors in AIA remains unknown. A comprehensive analysis of the urinary concentration of inflammatory mediators may afford a new research target in elucidating the pathophysiology of AIA. 相似文献
136.
137.
Tetsu?AkimotoEmail author Hiromichi?Yoshizawa Yuko?Watanabe Akihiko?Numata Tomoyuki?Yamazaki Eri?Takeshima Kana?Iwazu Takanori?Komada Naoko?Otani Yoshiyuki?Morishita Chiharu?Ito Kazuhiro?Shiizaki Yasuhiro?Ando Shigeaki?Muto Makoto?Kuro-o Eiji?Kusano 《BMC nephrology》2012,13(1):155
Background
Klotho is a single-pass transmembrane protein, which appears to be implicated in aging. The purpose of the present study was to characterize the relationship between the soluble Klotho level and renal function in patients with various degrees of chronic kidney disease (CKD).Methods
The levels of soluble Klotho in the serum and urine obtained from one hundred thirty-one CKD patients were determined by a sandwich enzyme-linked immunosorbent assay system.Results
The amount of urinary excreted Klotho during the 24 hr period ranged from 1.6 to 5178 ng/day (median 427 ng/day; interquartile range [IR] 56.8-1293.1), and the serum Klotho concentration ranged from 163.9 to 2123.7 pg/ml (median 759.7 pg/ml; IR 579.5-1069.1). The estimated glomerular filtration rate (eGFR) was significantly correlated with the log-transformed values of the amount of 24 hr urinary excreted Klotho (r?=?0.407, p?<?0.01) and the serum Klotho levels (r?=?0.232, p?<?0.01). However, a stepwise multiple regression analysis identified eGFR to be a variable independently associated only with the log-transformed value of the amount of 24-hr urinary excreted Klotho but not with the log-transformed serum Klotho concentration. Despite the strong correlation between random urine protein-to-creatinine ratio and the 24 hr urinary protein excretion (r?=?0.834, p?<?0.01), a moderate linear association was observed between the log-transformed value of the amount of 24 hr urinary excreted Klotho and that of the urinary Klotho-to-creatinine ratio (Klotho/Cr) in random urine specimens (r?=?0.726, p?<?0.01).Conclusions
The amount of urinary Klotho, rather than the serum Klotho levels, should be linked to the magnitude of the functioning nephrons in CKD patients. The use of random urine Klotho/Cr as a surrogate for the amount of 24-hr urinary excreted Klotho needs to be evaluated more carefully.138.
T Kanaoka K Tamura M Ohsawa H Wakui A Maeda T Dejima K Azushima S Haku H Mitsuhashi M Yanagi J Oshikawa K Uneda K Aoki T Fujikawa Y Toya K Uchino S Umemura 《Journal of clinical hypertension (Greenwich, Conn.)》2012,14(8):522-529
J Clin Hypertens (Greenwich). 2012;00:000–000. ©2012 Wiley Periodicals, Inc. Aliskiren is a direct renin inhibitor that exerts its effect at the rate‐limiting step of the renin‐angiotensin system. This study was performed to examine the beneficial effects of aliskiren‐based antihypertensive therapy on the ambulatory blood pressure (BP) profile, central hemodybamics, and arterial stiffness in untreated Japanese patients with mild to moderate hypertension. Twenty‐one Japanese nondiabetic patients with untreated mild to moderate essential hypertension were initially given aliskiren once daily at 150 mg, and the dose was titrated up to 300 mg as needed. After 12 weeks of aliskiren‐based therapy, the clinic, ambulatory, and central BP values as well as brachial‐ankle pulse wave velocity (baPWV) were all significantly decreased compared with baseline (clinic systolic BP, 151±11 mm Hg vs 132±11 mm Hg; clinic diastolic BP, 91±13 mm Hg vs 82±9 mm Hg; 24‐hour systolic BP, 144±12 mm Hg vs 133±11 mm Hg; 24‐hour diastolic BP, 88±8 mm Hg vs 81±9 mm Hg; central BP, 162±16 mm Hg vs 148±14 mm Hg; baPWV, 1625±245 cm/s vs 1495±199 cm/s; P<.05). These results show that aliskiren, as a first‐line regimen, improves the ambulatory BP profile and may have protective vascular effects in Japanese nondiabetic patients with untreated mild to moderate essential hypertension. 相似文献
139.
140.
Jun Takahashi Hirokazu Kobayashi Shinji Wakabayashi Masao Deguchi Hidehiro Ito Yuji Mogami Hirotaka Tanikawa Hiroyuki Nakagawa Hideki Moriya Ryohei Ashizawa Kenji Takahara Hisatoshi Kinoshita Yutaka Tateiwa Hiromichi Misawa Takahiro Tsutsumimoto Taku Nakakohji Yohei Yuzawa Akihito Sawaumi Yohei Hidai Satoshi Matsuda Isao Nakamura Shigeyuki Toba Mikio Kamimura Takeshi Nakane Hiroki Hirabayashi Hiroyuki Hashidate Nobuhide Ogihara Keijiro Mukaiyama Hiroyuki Kato Kuniyoshi Ohtsuka 《Journal of orthopaedic science》2013,18(2):208-215